Senior insider sale
President and CFO at BRIDGEBIO PHARMA, INC. — senior position signals high conviction
$888.4K
13.65K shares
What this filing means
TRIMARCHI THOMAS plans to sell 13.65K shares of BRIDGEBIO PHARMA, INC. valued at approximately $888.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/18/2026ACC: 0001950047-26-004675
Officer· President and CFO
Since Feb 2026
13.65K
Shares to sell
$888.4K
Approx. market value
13.65K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock
Not Applicable
5/16/2025
13.65KTotal acquired13.65K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/16/2025 | Restricted Stock Not Applicable | 13.65K | — |
| Total | 13.65K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
13.65K
Market value
$888.4K
5/18/2026
Total
Units
13.65K
Value
$888.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/18/2026 | 13.65K | $888.4K | NASDAQ | Planned |
| Total | 13.65K | $888.4K | ||